|
| |
| |
With a team of highly recognized American doctors and industry leaders in Pharmaceutical marketing and manufacturing, avVaa World Health Care Products is poised to globally market, manufacture and distribute a range of over-the-counter therapeutic skin care products to provide relief from the symptoms and reduce recurrences of specific skin disorders including psoriasis, dermatitis, and acne.
The Company’s confidence in the effectiveness and safety of these proven products is founded in extensive data including European clinical trials and evaluation and research spanning over a decade. avVaa ‘s major goal is to provide a better quality of life for global customers by relieving the severe and underlying pain caused by skin disorders, developing products with high customer need and large patient populations, while at the same time generating substantial returns for investors.
|
|
| |
|
|
| |
|
|
| |
A Social Problem |
|
| |
|
|
| |
The number of North Americans suffering from a range of common skin disorders, usually chronic and lifelong – that are known to have major psychological and physical side-effects – is quite staggering.
The leading health-related organizations in the U.S. specializing in skin problems have indicated that the estimated 40 million U.S. consumers spend US $4 Billion each year on over-the-counter products to ease their reoccurring pain and discomfort. |
|
| |
|
|
| |
|
|
| |
A Ready-Made Solution |
|
| |
|
|
| |
The Company's three flagship product lines include NEUROSKIN Spray, NEUROSKIN Acne Treatment and NEUROSKIN Itch Relief. All products are FDA registered and DIN approved. These products are now being manufactured and distributed worldwide. Future products, Nail Fit and Razor-Rash are also FDA
registered and DIN approved
and will be launched in Years 2 and 3. Seven other key products, including a line of animal/pet skin care products, will be introduced into the Americas on a priority basis defined by market potential studies for these products. The initial launch of products will take place in the United States.
There is presently no product on the market that has been a proven cure for psoriasis, eczema or acne. Patients who have been initially recommended by their doctor to use one of the present toxic therapies will eventually be forced to stop that therapy, and seek out a less toxic treatment. Now they will have the opportunity to seek out the effective NEUROSKIN line of products!
The need is great – and the potential is astounding! |
|
| |
|
|
| |
|
|
| |
A Powerful Marketing, Sales and Distribution Plan |
|
| |
|
|
| |
To achieve commercial success in the huge and competitive North American marketplace calls for a broad range of skill and expertise. avVaa has built relationships with some of the continent’s leading experts in the fields of pharmaceutical and health care research, production, marketing and sales.
avVaa will concentrate on building a strong relationship with trade distributors and end users to drive sales in the various market areas: direct consumer (Internet), institutional, mainstream retail and specialty merchants, private brand and cosmetic companies, and health and natural food stores. |
|
| |
|
|
| |
|
|
| |
Research & Development - A Proven Past – Securing the Future: |
|
| |
|
|
| |
Research is the base of all of avVaa ’s success and future plans. |
|
|
|
|
